INOVIO is a biotechnology company focused on rapidly bringing to market precisely designed DNA medicines to treat, cure, and protect people from diseases associated with HPV, cancer, and infectious diseases. INOVIO is the first and only company to have clinically demonstrated that DNA medicine can be delivered directly into cells in the body via a proprietary smart device to produce a robust and tolerable immune response. Specifically, INOVIO's lead candidate VGX-3100, currently in Phase 3 trials for precancerous cervical dysplasia, demonstrated it destroyed and cleared high-risk HPV 16 and 18 in a Phase 2b clinical trial. High-risk HPV is responsible for 70% of cervical cancer, 90% of anal cancer, and 69% of vulvar cancer.

OPKO Diagnostics LLC engages in the provision of health services. It develops blood testing devices for use in homes and doctors offices. The company was founded by Vincent Linder, George M. Whitesides, David Steinmiller, and Samuel K. Sia in 2004 and is headquartered in Woburn, MA.

Cytosystems is a pathology company that develops non-invasive cancer diagnostic and stratification technologies for initially for the management of bladder cancer. The company’s first product, BladderLight™, is an integrated and automated digital pathology solution using a big data systems approach for the diagnosis and monitoring of bladder cancer. Cytosystems has developed two patent-pending technologies: a point of care cell collection device which optimizes analyte quality at point of patient care and the use of artificial intelligence pattern recognition software to interrogate and objectively classify individual urothelial cells as cancer positive or negative. This whole-cell approach can help with clinical decision making and provides a highly sensitive and specific test which achieves the challenging performance levels demanded of a non-invasive test by patients and clinicians.

Hybritech Incorporated develops and markets monoclonal antibodies. It is a biotechnology company that uses these antibodies to make diagnostic and medical monitoring tests to identify a variety of infectious, viral and cancer-related diseases such as colon and prostate cancer, infertility, allergies, and issues that arise during pregnancy. Hybritech Incorporated was established in 1978 and is based in San Diego, California. Hybritech, Inc. operates as a subsidiary of Danaher Corp.

Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD.

The Company has assembled several bioactive technologies, including human and xenotypic monoclonal antibodies of the IgG and IgE class that can induce tumor specific immunity and enhance clinical outcome. Several of the lead components have clinical track records and extensive development dossiers that can be exploited to be integral to combinatorial immunooncology treatment strategies.

Cetus Corporation was one of the first biotechnology companies. It was established in Berkeley, California in 1971, but conducted most of its operations in nearby Emeryville. Before merging with another company in 1991, it developed several significant pharmaceutical drugs as well as a revolutionary DNA amplification technique.

Manufactures vaccines for diseases like hepatitis, influenza, rubella and typhoid fever

Autobio Diagnostics is a company mainly engaged in development, manufacture and sales of diagnostics products.

DKFZ Deutsche Krebsforschungszentrum is a German private company that operates as a cancer research center.

Focuses on the research and development of foreign antibodies

Research Corporation Technologies, Inc. provides investment related services. It operates as technology development company that typically invests in new technology platforms in life sciences, healthcare technology, biomedical, preclinical and clinical-stage therapeutics, devices, drugs, and diagnostics, medical devices, and biotech tools for gene expression and protein production with medical devices. The company was founded in 1987 and is headquartered in Tucson, AZ.

Part of Freenome Holdings, Inc., Oncimmune Germany GmbH is a German company located in Dortmund. The firm engages in trading of pharma products. It was founded in 2019.

AltaRex Medical Corp., a subsidiary of Endo International Plc, is a Canadian company located in Edmonton, AB, that develops and research foreign antibodies for cancer and life-threatening disease treatment. It was acquired by ViRexx Medical Corp., now a subsidiary of Endo International Plc on December 13, 2004 for $22.66 million.

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Kenilworth, NJ.

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

Shanghai Youke Instrument Co., Ltd., established on 2007-01-11, The scope of business includes the manufacture of instruments and meters,processing,wholesale,retail,chemical reagent(Removal of hazardous chemicals,Monitor Chemicals,civilian explosives,Precursor),glassware,Office Supplies,computer,Wholesale of software and auxiliary equipment,retail,computer software development,Engaged in technical consultation in the field of instrumentation technology,Technical Services,Engaged in the import and export of goods and technology. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Quest PharmaTech, Inc. is a biotechnology company, which develops and commercializes antibody based immunotherapeutic products for cancer. It focuses on developing products utilizing proprietary transdermal delivery technologies with a focus on dermatology and wound healing applications. The firm is developing targeted cancer therapy with its lead product MAb AR9.6, under development for a novel target, truncated O-glycans on MUC16. The company was founded in 1996 and is headquartered in Edmonton, Canada.

Advaxis is a clinical-stage biotechnology company developing the next generation of immunotherapies for cancer and infectious diseases. Advaxis immunotherapies are based on a novel platform technology using live, attenuated bacteria that are bio-engineered to secrete antigen/adjuvant fusion protein(s) designed to redirect the powerful immune response all human beings have to the bacterium to the cancer itself. ADXS-HPV is being evaluated in four clinical trials for HPV-associated diseases: recurrent/refractory cervical cancer (India), locally advanced cervical cancer (GOG/NCI US study), head and neck cancer (CRUK study), and anal cancer (BrUOG). Over fifteen (15) distinct constructs are in various stages of development, developed directly by the Company and through strategic collaborations with recognized centers of excellence.